USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS UP TO WEEK 104 OF THE STARDUST TRIAL
Laurent Peyrin-Biroulet 1
Severine Vermeire 2
Geert R. D'Haens 3
Julian Panés 4
Axel Dignass 5
Fernando Magro 6
Maciej Nazar 7
Manuela Le Bars 8
Marjolein Lahaye 9
Lioudmila Ni 10
Ivana Bravatà 11
Daniel R. Gaya 12
Silvio Danese 13
1 University Hospital of Nancy, University of Lorraine, Houdemont, France
2 University Hospitals Leuven, Leuven, Belgium
3 University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands
4 Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
5 Agaplesion Markus Hospital, Goethe University, Frankfurt/ Main, Germany
6 Hospital de São João, Porto, Portugal
7 Janssen-Cilag Polska Sp. z .o.o, Warsaw, Poland
8 Janssen-Cilag, Issy Les Moulineaux, France
9 Janssen-Cilag BV, Breda, Netherlands
10 Janssen-Cilag Russia, Moscow, Russian Federation
11 Janssen-Cilag, Milan, Italy
12 Glasgow Royal Infirmary, Glasgow, United Kingdom
13 IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]